By JESSICA DaMASSA, WTF HEALTH
As if one client digital well being firm with an $18.5B exit wasn’t sufficient, Livongo founder Glen Tullman has determined to present the transformation of healthcare one other go – this time as Govt Chairman & CEO of Transcarent. Matthew Holt and I sit down with Glen to listen to in regards to the “new type of expertise” that Transcarent is providing self-insured employers and their workers: one centered on offering unbiased data, steering for accessing high-value healthcare, and an at-risk mannequin that guarantees to share again the monetary advantages related to higher healthcare decision-making.
Might you take into account Transcarent an aggregator, a healthcare navigator-PLUS, or is it extra like a next-gen well being plan that does every little thing however course of claims? Glen talks about how his crew was “requested” to leap into offering a greater expertise for this type of healthcare service, particulars what the corporate wants subsequent, and explains the position of Bridge Well being, which merged with Transcarent in October 2020 when the corporate closed its $44M Sequence A. Acquainted traders, Basic Catalyst and Glen’s personal 7Wire Ventures, have led the funding for Transcarent and we discover out if there shall be any further help from the Well being Assurance Acquisition Company (the SPAC that Glen launched in partnership with Basic Catalyst’s Hemant Taneja and others) that would doubtlessly present a automobile for taking the enterprise public. And, what about Teladoc Well being? With a seat on TDOC’s Board, does Transcarent’s dedication to providing “unbiased” path to the very best healthcare put Glen right into a battle of curiosity? That is one catch-up chat you’re not going to wish to miss!